Retrospective Epidemiological Study of Locally Advanced Non Small Cell Lung Cancer Patients in Brazil
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 403
- 试验地点
- 1
- 主要终点
- Overall survival
研究概览
简要总结
RELANCE is a large multi-institutional study that aims to retrospectively collect information about diagnostic, treatment and outcome of patients diagnosed with locally advanced NSCLC in Brazil. It is hypothesized that there is a great heterogeneity in treatment patterns owing to inequities in access to adequate staging methods, optimal treatment and multidisciplinary teams in Brazil.
详细描述
RELANCE study will collect sociodemographic and clinical data of patients diagnosed with locally advanced NSCLC in the period of January 2015 and Jun 2019 in the participating institutions. Socio-demographic characteristics, clinicopathological features, treatments patterns and outcomes will be recovered from medical charts. Disease status and survival data will be collected up to the last date of follow-up June 2021.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients aged 18 years or older;
- •Histologically or cytological diagnosis of NSCLC in the period of January 2015 to December 2016;
- •Locally Advanced NSCLC defined as clinical stage IIIA and IIIB according to 7th Edition TNM Staging System;
- •Any NSCLC histological subtype and molecular mutation;
- •Any Eastern Cooperative Oncology Group (ECOG) Performance Status (0 to 4) at diagnosis;
- •Patients assigned by treating physician to any therapy or palliative care;
- •Access to patient medical chart for data collection.
排除标准
- •Small cell lung cancer and non-invasive NSCLC;
- •Synchronic NSCLC or second primary tumour in the last 5 years (except non-melanoma skin cancer).
结局指标
主要结局
Overall survival
时间窗: Up to June 30, 2018
defined as time from diagnosis to death of any cause;
次要结局
- Progression free survival(Up to June 30, 2018)
- Time to next treatment(Up to June 30, 2018)